Published in Mod Rheumatol on March 04, 2008
The antiphospholipid antibody syndrome: a case report. Int Med Case Rep J (2012) 1.05
The NF-κB specific inhibitor DHMEQ prevents thrombus formation in a mouse model of antiphospholipid syndrome. J Nephropathol (2013) 0.83
Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome. Clin Exp Immunol (2012) 0.81
Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis (2004) 1.91
Sulphamethoxazole-trimethoprim in the treatment of limited paranasal Wegener's granulomatosis. Rheumatology (Oxford) (2002) 1.41
Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology (Oxford) (2003) 1.38
Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis (2003) 1.38
Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) (2005) 1.35
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. Arthritis Rheum (2010) 1.26
Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus. Lupus (2003) 1.21
The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus (2009) 1.17
Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis (2003) 1.14
The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus (2009) 1.14
Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis (2006) 1.00
Intracerebral arterial stenosis with neurological events associated with antiphospholipid syndrome. Rheumatology (Oxford) (2005) 0.99
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev (2005) 0.97
Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford) (2004) 0.96
Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis (2005) 0.94
Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study. Ann Rheum Dis (2003) 0.93
Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis (2005) 0.89
Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures. Ann Rheum Dis (2004) 0.88
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford) (2002) 0.88
The spectrum of ASIA: 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants'. Lupus (2012) 0.86
Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. Arthritis Rheum (2004) 0.84
Neurological manifestations of anti-phospholipid (Hughes) syndrome. Clin Exp Rheumatol (2005) 0.84
Periorbital oedema in systemic lupus erythematosus. Lupus (2003) 0.84
Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis. Rheumatology (Oxford) (2008) 0.84
Mycophenolate mofetil treatment in resistant myositis. Rheumatology (Oxford) (2006) 0.83
Association of HLA-DM polymorphism with the production of antiphospholipid antibodies. Ann Rheum Dis (2004) 0.83
Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy. Rheumatology (Oxford) (2005) 0.83
Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome. J Clin Immunol (2003) 0.83
Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. Rheumatology (Oxford) (2004) 0.82
Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome. Clin Exp Immunol (2012) 0.81
Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance. Ann Rheum Dis (2005) 0.81
Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid anti-bodies. Clin Exp Rheumatol (2006) 0.81
Theory, targets and therapy in systemic lupus erythematosus. Lupus (2005) 0.80
Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis (2002) 0.79
Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity. Ann Rheum Dis (2003) 0.79
Hypertension as the presenting feature of the antiphospholipid syndrome. Lupus (2002) 0.79
Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. Rheumatology (Oxford) (2004) 0.79
Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil. Clin Exp Rheumatol (2005) 0.78
Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome. Lupus (2003) 0.78
Prevalence of an abnormal ankle-brachial index in patients with antiphospholipid syndrome with pregnancy loss but without thrombosis: a controlled study. Ann Rheum Dis (2006) 0.77
Syndrome X and Hughes syndrome. Lupus (2002) 0.77
Treatment of mesenteric angina with prolonged anticoagulation in a patient with antiphospholipid (Hughes) syndrome and coeliac artery stenosis. Ann Rheum Dis (2006) 0.77
Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies. Ann Rheum Dis (2005) 0.77
Human Ro60 (SSA2) genomic organization and sequence alterations, examined in cutaneous lupus erythematosus. Br J Dermatol (2002) 0.76
Migraine and antiphospholipid antibodies: no association found in migraine-discordant monozygotic twins. Cephalalgia (2008) 0.76
Heparin and osteoporosis during pregnancy: 2002 update. Lupus (2002) 0.76
The point prevalence of an abnormal ankle-brachial index in antiphospholipid antibody negative patients with livedo reticularis: a controlled study. Ann Rheum Dis (2008) 0.76
Perspectives on the changing face of lupus mortality. Autoimmun Rev (2004) 0.76
Increased cutaneous reactions to hydroxychloroquine (Plaquenil) possibly associated with formulation change: comment on the letter by Alarcón. Arthritis Rheum (2002) 0.75
Dermatomyositis developing in a Duchenne muscular dystrophy carrier. Rheumatology (Oxford) (2004) 0.75
Heparin, antiphospholipid antibodies and the brain. Lupus (2012) 0.75
Renal microinfarction in Behçet's disease. Rheumatology (Oxford) (2003) 0.75
MALToma and lupus. Lupus (2005) 0.75
Endocarditis and ulnar artery aneurysm as presenting features of antiphospholipid syndrome and polyarteritis nodosa. Lupus (2005) 0.75
Lessons from the "Euro-Lupus Cohort". Ann Med Interne (Paris) (2002) 0.75
Multiple sclerosis and the antiphospholipid (Hughes) syndrome: a common differential diagnosis? Clin Exp Rheumatol (2004) 0.75